Quantinno Capital Management LP Grows Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Quantinno Capital Management LP raised its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 31.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 56,661 shares of the company's stock after acquiring an additional 13,485 shares during the period. Quantinno Capital Management LP's holdings in Bath & Body Works were worth $1,809,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. CWM LLC grew its position in shares of Bath & Body Works by 6.6% in the 2nd quarter. CWM LLC now owns 5,072 shares of the company's stock worth $198,000 after buying an additional 314 shares during the last quarter. PGGM Investments purchased a new stake in shares of Bath & Body Works in the 2nd quarter worth about $509,000. Envestnet Portfolio Solutions Inc. lifted its position in shares of Bath & Body Works by 18.0% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 6,572 shares of the company's stock worth $257,000 after purchasing an additional 1,001 shares during the period. Blue Trust Inc. lifted its position in shares of Bath & Body Works by 23.4% in the 2nd quarter. Blue Trust Inc. now owns 2,767 shares of the company's stock worth $108,000 after purchasing an additional 524 shares during the period. Finally, Raymond James & Associates lifted its position in shares of Bath & Body Works by 22.8% in the 2nd quarter. Raymond James & Associates now owns 83,974 shares of the company's stock worth $3,279,000 after purchasing an additional 15,602 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Stock Down 2.4 %

Bath & Body Works stock traded down $0.92 during mid-day trading on Thursday, reaching $37.42. 2,815,750 shares of the company's stock traded hands, compared to its average volume of 4,020,733. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99. The company has a market cap of $8.10 billion, a price-to-earnings ratio of 9.13, a PEG ratio of 1.37 and a beta of 1.83. The stock has a 50 day moving average of $32.42 and a two-hundred day moving average of $34.85.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the prior year, the firm posted $0.48 earnings per share. The business's revenue for the quarter was up 3.1% on a year-over-year basis. As a group, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.26 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.14%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works's dividend payout ratio is currently 19.51%.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of the company's stock in a transaction on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.27% of the company's stock.

Wall Street Analyst Weigh In

BBWI has been the subject of several research analyst reports. TD Cowen raised their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a research report on Thursday. Bank of America lowered their price target on shares of Bath & Body Works from $54.00 to $45.00 and set a "buy" rating for the company in a research report on Thursday, August 29th. Telsey Advisory Group reissued an "outperform" rating and set a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a "buy" rating in a research report on Tuesday, November 26th. Finally, Piper Sandler lifted their price target on shares of Bath & Body Works from $35.00 to $36.00 and gave the company a "neutral" rating in a research report on Tuesday, November 26th. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $42.50.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.